Back to Search
WILLIAM INGRAM, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1225127624IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
24830(SC)
CMS Specialties
PrimaryPATHOLOGY
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 2003
Research & Publications (20)
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study.
PMID 19388935·Br J Haematol·2009
8-other
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of cultures.
PMID 19283381·Cancer Immunol Immunother·2009
8-other
IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome.
PMID 19210506·Br J Haematol·2009
4-observational
Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center.
PMID 19509623·J Trauma·2009
8-other
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
PMID 18318762·Br J Haematol·2008
4-observational
Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling.
PMID 17873912·Oncogene·2008
7-preclinical
N15 Cro and lambda Cro: orthologous DNA-binding domains with completely different but equally effective homodimer interfaces.
PMID 18369196·Protein Sci·2008
8-other
Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative.
PMID 18037939·Bone Marrow Transplant·2008
8-other
Transitive homology-guided structural studies lead to discovery of Cro proteins with 40% sequence identity but different folds.
PMID 18227506·Proc Natl Acad Sci U S A·2008
8-other
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
PMID 17608767·Br J Haematol·2007
8-other
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.
PMID 17634407·Blood·2007
8-other
The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells.
PMID 17686061·Br J Haematol·2007
8-other
The accuracy of thoracic ultrasound for detection of pneumothorax is not sustained over time: a preliminary study.
PMID 17563653·J Trauma·2007
4-observational
Can secondary extremity compartment syndrome be diagnosed earlier?
PMID 18005761·Am J Surg·2007
8-other
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).
PMID 17412885·Blood·2007
8-other
Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival.
PMID 17704796·Bone Marrow Transplant·2007
8-other
The JAK2 V617F mutation is rare in RARS but common in RARS-T.
PMID 16932338·Leukemia·2006
4-observational
Relationship between sequence determinants of stability for two natural homologous proteins with different folds.
PMID 16939206·Biochemistry·2006
4-observational
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.
PMID 16939494·Br J Haematol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 N BROADWAY, WEINBERG 2267
BALTIMORE, MD 21231 - Phone
- (410) 955-3580
Quick Facts
- NPI
- 1225127624
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile